Ursula Seidler

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

Brian G. Feagan, William J. Sandborn, Christopher Gasink et al. · New England Journal of Medicine · 2016 · 1.8K citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity

Sya N. Ukena, Anurag Kumar Singh, Ulrike Dringenberg et al. · PLoS ONE · 2007 · 475 citations · Full text

Life Sciences, Immunology, Microbiology +17

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study

Brian G. Feagan, William J. Sandborn, Geert D’Haens et al. · The Lancet · 2017 · 446 citations · Full text

Life Sciences, Immunology, Pharmacology +16

Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial

Brian G. Feagan, Silvio Danese, Edward V. Loftus et al. · The Lancet · 2021 · 437 citations

Medicine, Clinical Sciences, Pharmacotherapy +15

Intestinal Secretory Defects and Dwarfism in Mice Lacking cGMP-Dependent Protein Kinase II

Alexander Pfeifer, Attila Aszódi, Ursula Seidler et al. · Science · 1996 · 409 citations

Life Sciences, Molecular Biology, Physiology +16